Regulus Therapeutics
RGLS
#6913
Rank
$0.56 B
Marketcap
$8.16
Share price
0.00%
Change (1 day)
436.84%
Change (1 year)

Market capitalization of Regulus Therapeutics (RGLS)

Last known market cap: $0.56 Billion USD

On August 27, 2025 Regulus Therapeutics had a market cap of $0.56 Billion USD. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regulus Therapeutics from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025$0.56 B460.08%
2024$0.10 B289.68%
2023$25.88 M12.2%
2022$23.07 M-49.82%
2021$45.98 M-46.37%
2020$85.73 M358.29%
2019$18.7 M127.96%
2018$8.2 M-92.41%
2017$0.10 B-9.21%
2016$0.11 B-74.07%
2015$0.45 B-41.5%
2014$0.78 B154.23%
2013$0.30 B36.8%
2012$0.22 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
$107.59 B 18,944.47%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
$27.13 B 4,702.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$122.77 B 21,632.71%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$301.09 B 53,196.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
$109.22 B 19,233.84%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
$0.14 B-75.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
$2.97 B 427.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
$42.52 B 7,427.55%๐Ÿ‡บ๐Ÿ‡ธ USA